METTL3 and colorectal carcinoma: F. nucleatum induces a dramatic decline of m6A modifications in CRC cells and patient-derived xenograft (PDX) tissues by downregulating an m6A methyltransferase, METTL3, contributing to the induction of CRC aggressiveness (71).